Literature DB >> 12727945

X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene.

Nathalie Massin1, Christophe Pêcheux, Corinne Eloit, Jean-Louis Bensimon, Julie Galey, Frédérique Kuttenn, Jean-Pierre Hardelin, Catherine Dodé, Philippe Touraine.   

Abstract

Kallmann syndrome (KS) is characterized by the association of hypogonadotropic hypogonadism and anosmia. The gene underlying the X chromosome-linked form of the disease, KAL-1, consists of 14 coding exons. It encodes a glycoprotein, anosmin-1, which is involved in the embryonic migration of GnRH-synthesizing neurons and the differentiation of the olfactory bulbs. We describe herein the clinical heterogeneity in three affected brothers who carry a large deletion (exons 3-13) in KAL-1. All three had a history of hypogonadotropic hypogonadism with delayed puberty. Although brain magnetic resonance imaging showed hypoplastic olfactory bulbs in the three siblings, variable degrees of anosmia/hyposmia were shown by olfactometry. In addition, these brothers had different phenotypic anomalies, i.e. unilateral renal aplasia (siblings B and C), high-arched palate (sibling A), brachymetacarpia (sibling A), mirror movements (siblings A and B), and abnormal eye movements (sibling C). Last but not least, sibling A suffered from a severe congenital hearing impairment, a feature that had been reported in KS but had not yet been ascribed unambiguously to the X-linked form of the disease. The variable phenotype, both qualitatively and quantitatively, in this family further emphasizes the role of putative modifier genes, and/or epigenetic factors, in the expressivity of the X-linked KS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727945     DOI: 10.1210/jc.2002-021981

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications.

Authors:  Hilana M Lewkowitz-Shpuntoff; Virginia A Hughes; Lacey Plummer; Margaret G Au; Richard L Doty; Stephanie B Seminara; Yee-Ming Chan; Nelly Pitteloud; William F Crowley; Ravikumar Balasubramanian
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

2.  Adult-onset idiopathic hypogonadotropic hypogonadism: possible aetiology, clinical manifestations and management.

Authors:  Jiang-Feng Mao; Min Nie; Shuang-Yu Lu; Xue-Yan Wu
Journal:  Asian J Androl       Date:  2010-06-07       Impact factor: 3.285

Review 3.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 4.  Isolated GnRH deficiency: a disease model serving as a unique prism into the systems biology of the GnRH neuronal network.

Authors:  Ravikumar Balasubramanian; William F Crowley
Journal:  Mol Cell Endocrinol       Date:  2011-07-12       Impact factor: 4.102

Review 5.  New understandings of the genetic basis of isolated idiopathic central hypogonadism.

Authors:  Marco Bonomi; Domenico Vladimiro Libri; Fabiana Guizzardi; Elena Guarducci; Elisabetta Maiolo; Elisa Pignatti; Roberta Asci; Luca Persani
Journal:  Asian J Androl       Date:  2011-12-05       Impact factor: 3.285

6.  Kallmann syndrome and paranoid schizophrenia: a rare combination.

Authors:  Willem M A Verhoeven; Jos I M Egger; Johannes E Hovens; Lies Hoefsloot
Journal:  BMJ Case Rep       Date:  2013-01-17

7.  Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.

Authors:  Flavia Amanda Costa-Barbosa; Ravikumar Balasubramanian; Kimberly W Keefe; Natalie D Shaw; Nada Al-Tassan; Lacey Plummer; Andrew A Dwyer; Cassandra L Buck; Jin-Ho Choi; Stephanie B Seminara; Richard Quinton; Dorota Monies; Brian Meyer; Janet E Hall; Nelly Pitteloud; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

8.  Kallmann syndrome.

Authors:  Catherine Dodé; Jean-Pierre Hardelin
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

9.  Two cases of Kallmann syndrome associated with empty sella.

Authors:  Cristina Micheletto Dallago; Denise Dotta Abech; Julia Fernanda Semmelmann Pereira-Lima; Caroline Garcia Soares Leães; Rafael Loch Batista; Ericka Barbosa Trarbach; Miriam da Costa Oliveira
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 10.  Kallmann syndrome: fibroblast growth factor signaling insufficiency?

Authors:  Catherine Dodé; Jean-Pierre Hardelin
Journal:  J Mol Med (Berl)       Date:  2004-09-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.